About Primas Bioscience
Primas Bioscience is a company based in Chennai (India) founded in 2019 by Kabilan Chandrasekaran and Muthu Dhanraj. Primas Bioscience has raised $506.57 thousand across 1 funding round from investors including Lakshmi Narayanan, T K Chandiran and Lakshmi Narayanan. The company has 1 employees as of April 09, 2024. Primas Bioscience offers products and services including DHA Omega-3 and Nutritional Supplements. Primas Bioscience operates in a competitive market with competitors including Polaris, AlgaeCytes, Algisys, Solutex and Coromega, among others.
- Headquarter Chennai, India
- Employees 1 as on 09 Apr, 2024
- Founders Kabilan Chandrasekaran, Muthu Dhanraj
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Primas Bioscience Private Limited
- Date of Incorporation 22 May, 2019
- Jurisdiction Chennai, Tamil Nadu, India
-
Annual Revenue
$395.46 (USD)196.31as on Mar 31, 2023
-
Net Profit
-$102.15 K (USD)-849.64as on Mar 31, 2023
-
EBITDA
-$52.28 K (USD)-230.7as on Mar 31, 2023
-
Total Equity Funding
$506.57 K (USD)
in 1 rounds
-
Latest Funding Round
$506.57 K (USD), Angel Round
Jul 04, 2022
-
Investors
& 2 more
-
Employee Count
1
as on Apr 09, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Primas Bioscience
Primas Bioscience offers a comprehensive portfolio of products and services, including DHA Omega-3 and Nutritional Supplements.
Provides essential fatty acids for brain and heart health benefits.
Offers omega-3 based solutions for immune and inflammatory support.
Funding Insights of Primas Bioscience
Primas Bioscience has successfully raised a total of $506.57K through 1 strategic funding round. The most recent funding activity was a Angel Round of $506.57 thousand completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Primas Bioscience
Primas Bioscience has secured backing from 3 investors, including angel investors. Prominent investors backing the company include Lakshmi Narayanan, T K Chandiran and Lakshmi Narayanan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
LN
Lakshmi Narayanan |
-
|
Locked | Locked | Locked |
|
TK
T K Chandiran |
-
|
Locked | Locked | Locked |
|
LN
Lakshmi Narayanan |
Angel investor, ex-CEO of Cognizant, focused on tech and innovation
|
Locked | Locked | Locked |
Investor details for Primas Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Primas Bioscience
Investment portfolio details for Primas Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Primas Bioscience
Detailed financials for Primas Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Primas Bioscience Comparisons
Peer comparison for Primas Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Primas Bioscience
Primas Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Polaris, AlgaeCytes, Algisys, Solutex and Coromega, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nutritional functional foods and Omega-3 ingredients are developed.
|
|
| Locked | Locked | Locked |
Omega 3 oils and bio-actives are manufactured from freshwater algae.
|
|
| Locked | Locked | Locked |
Algal-based EPA omega-3 oils and vegan protein are produced.
|
|
| Locked | Locked | Locked |
Solutex is recognized as a leading manufacturer of omega-3 ingredients.
|
|
| Locked | Locked | Locked |
Provides emulsified Omega-3 supplements for daily health and wellness needs.
|
|
| Locked | Locked | Locked |
Personalized supplements are manufactured based on omega-6/omega-3 ratio tests.
|
Detailed competitors of Primas Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Primas Bioscience
Complete news archive for Primas Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Primas Bioscience
Primas Bioscience was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Primas Bioscience is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Primas Bioscience is a funded company, having raised a total of $506.57K across 1 funding round to date.
As of Apr 09, 2024, the latest employee count at Primas Bioscience is 1.
Annual revenue of Primas Bioscience is $395.46 as on Mar 31, 2023.
Primas Bioscience was founded in 2019 in Chennai, India, within the bioscience sector. Omega-3 fatty acids are manufactured using patented technology derived from microbial sources. Products such as PrimasDHA-10, PrimasDHA-40, and antioxidants have been created. These supplements are utilized to support immune system function and blood pressure regulation. Operations focus on nutritional supplement development for health applications.
Primas Bioscience's top competitors include Zinzino, AlgaeCytes and Algisys.
Primas Bioscience offers DHA Omega-3 and Nutritional Supplements.
Primas Bioscience has 3 investors. Key investors include Lakshmi Narayanan, T K Chandiran, and Lakshmi Narayanan.
The valuation of Primas Bioscience is $1.58M as of Jul 2022.